RxDoctor Payments Data

Christopher Ward, MD

Vascular Surgery · Coeur D Alene, IDNPI 1598964215

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,685 of the $5,224 with a category attached, or 89.7%. 26 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 33.3% of the total.

$5,224in general payments, 2019–2025

Across 166 payments — averaging $31.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$2K
  • Medtronic$1K
  • Abbott$339
  • Penumbra, Inc.$321
  • Johnson & Johnson$265
  • Cook Medical LLC$247
  • plus $1K from 20 others

What the payments were for

  • Travel & lodging$53910%
  • Food & beverage$4,68590%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,224 in reported general payments places this provider in the 70th percentile of 28 vascular surgery providers in Idaho.

See all vascular surgery providers in Idaho

Medicare billing

Part B allowed, 2024
$111,621
Medicare patients
480
Services billed
953

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate21$265
Atorvastatin Calcium16$144

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Coeur D Alene

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →